Approvals/CIMA-AEMPS/LEVOSIMENDAN WAYMADE 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

LEVOSIMENDAN WAYMADE 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Waymade B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 86348371ee1f01be
Drug Cima Aemps Name: LEVOSIMENDAN WAYMADE 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number: 89860
Holder Company Name: Waymade B.V.
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2024-12-09
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 2,5 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Waymade B.V.

LEVOSIMENDAN

2,5 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 9, 2024

Approval ID

86348371ee1f01be

Type

Standard